BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20591084)

  • 21. The use of a single-pill calcium channel blocker/statin combination in the management of hypertension and dyslipidemia: a randomized, placebo-controlled, multicenter study.
    Neutel JM; Bestermann WH; Dyess EM; Graff A; Kursun A; Sutradhar S; Yunis C
    J Clin Hypertens (Greenwich); 2009 Jan; 11(1):22-30. PubMed ID: 19125855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia.
    Ge CJ; Lu SZ; Chen YD; Wu XF; Hu SJ; Ji Y
    Heart Vessels; 2008 Mar; 23(2):91-5. PubMed ID: 18389332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EFFICACY AND SAFETY OF A SINGLE-PILL COMBINATION OF ATORVASTATIN/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA.
    Naydenov Naydenov S; Margaritov Runev N; Ivanov Manov E; Georgieva Torbova-Gigova S
    Acta Clin Croat; 2018 Sep; 57(3):464-472. PubMed ID: 31168179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving adherence with amlodipine/atorvastatin therapy: IMPACT study.
    Oliver S; Jones J; Leonard D; Crabbe A; Delkhah Y; Nesbitt S
    J Clin Hypertens (Greenwich); 2011 Aug; 13(8):598-604. PubMed ID: 21806770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atorvastatin and amlodipine co-treatment in ASCOT--LLA shows benefit.
    Cardiovasc J S Afr; 2007; 18(1):43-4. PubMed ID: 17392998
    [No Abstract]   [Full Text] [Related]  

  • 26. Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees.
    Chapman RH; Yeaw J; Roberts CS
    BMC Cardiovasc Disord; 2010 Jun; 10():29. PubMed ID: 20565779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease.
    Curran MP
    Drugs; 2010; 70(2):191-213. PubMed ID: 20108992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atorvastatin calcium plus amlodipine for the treatment of hypertension.
    Delgado-Montero A; Zamorano JL
    Expert Opin Pharmacother; 2012 Dec; 13(18):2673-85. PubMed ID: 23140185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen.
    Patel BV; Leslie RS; Thiebaud P; Nichol MB; Tang SS; Solomon H; Honda D; Foody JM
    Vasc Health Risk Manag; 2008; 4(3):673-81. PubMed ID: 18827917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.
    Richard Hobbs FD; Gensini G; John Mancini GB; Manolis AJ; Bauer B; Genest J; Feldman RD; Harvey P; Jenssen TG; da Silva PM;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):472-80. PubMed ID: 19407658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction in cardiovascular risk using a proactive multifactorial intervention is consistent among patients residing in Pacific Asian and non-Pacific Asian regions: a CRUCIAL trial subanalysis.
    Cho EJ; Kim JH; Sutradhar S; Yunis C; Westergaard M;
    Vasc Health Risk Manag; 2014; 10():145-56. PubMed ID: 24707184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of fix dose combination (atorvastatin and amlodipine) in treatment of uncontrolled hypertension and dyslipidemia.
    Bashir S; Sherwani MU; Shabbir I; Batool A
    J Ayub Med Coll Abbottabad; 2011; 23(3):97-100. PubMed ID: 23272446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Switching from Treatment with Amlodipine and Atorvastatin Using Two Pills to an Equal Dose of Single-Pill Therapy in Japanese Outpatients.
    Kawada Y; Kubo T; Baba Y; Hirota T; Tanioka K; Yamasaki N; Kitaoka H
    Acta Med Okayama; 2020 Apr; 74(2):103-108. PubMed ID: 32341583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Benefit of Fixed-Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia.
    Lin CP; Hsu TJ; Tung YC; Hsiao FC; Chou SH; Lin YS; Chen SW; Chu PH
    J Am Heart Assoc; 2024 May; 13(9):e033780. PubMed ID: 38686894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine/atorvastatin gemini study).
    Blank R; LaSalle J; Reeves R; Maroni J; Tarasenko L; Sun F
    J Clin Hypertens (Greenwich); 2005 May; 7(5):264-73. PubMed ID: 15886529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy.
    Cowie MR
    Int J Clin Pract; 2005 Jul; 59(7):839-46. PubMed ID: 15963213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.
    Athyros VG; Papageorgiou AA; Mercouris BR; Athyrou VV; Symeonidis AN; Basayannis EO; Demitriadis DS; Kontopoulos AG
    Curr Med Res Opin; 2002; 18(4):220-8. PubMed ID: 12201623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and rationale of a real-life study to compare treatment strategies for cardiovascular risk factors: the CRUCIAL study.
    Zamorano J; Erdine S; Lopez AP; Kim JH; Al Khadra A; Westergaard M; Sutradhar S; Yunis C;
    Postgrad Med; 2010 Mar; 122(2):7-15. PubMed ID: 20203451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification].
    Li XP; Duan J; Zhao SP; Tan MY; Xu ZM; Zhang DQ
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2399-403. PubMed ID: 17156651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.